Isolation of platelets
A medical device is utilized for the loading of the platelets.
Platelet concentrates, obtained from whole blood, are automatically loaded with drugs/compounds.
Platelet-mediated delivery of oligonucleotides, small molecule, and antibodies/proteins
In vivo target
Platelet concentrates as drug carriers for the therapeutic targeting of solid
cancer and of inflammatory diseases (Rheumatoid arthritis).
Our technology exploits the unique properties of platelets which have been shown to be able to deliver nucleic acids, proteins and small molecules to various cell types, as cancer cells, pathogen agents, and subendothelial layer. Plasfer will enhance the capability of platelets to deliver payloads to specific cell and tissue types.
Easy to separate, easy to load with payloads, easy targeting in vivo
A portfolio of IP for using exclusively platelets as drug delivery tool
An high qualified and differentiated team with a strong and acknowledged scientific background
A technology with highly innovative impact in cell therapy
Plasfer is in preclinical stage. Plasfer will lead the power of platelets to deliver nucleic acids to treat a diverse array of cancer and non-cancer indications.
Plasfer took part in the “19TH ANNUAL BIOTECH IN EUROPE FORUM” in Basel from S...
Perugia, 17/01/19 Si invitano i soci a prendere visione della documentazione scaricabile d...